CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+9.19%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$709M
AUM Growth
-$77.6M
(-9.9%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-16.94%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
452
New
12
Increased
91
Reduced
283
Closed
40
Top Buys
| 1 |
Apple
AAPL
|
$9.08M |
| 2 |
Applied Materials
AMAT
|
$5.39M |
| 3 |
Arista Networks
ANET
|
$5.26M |
| 4 |
Amphenol
APH
|
$5.07M |
| 5 |
Alibaba
BABA
|
$4.29M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.02M |
| 2 |
Adobe
ADBE
|
$7.95M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$7.6M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$6.84M |
| 5 |
Lam Research
LRCX
|
$5.23M |
Sector Composition
| 1 | Technology | 43.87% |
| 2 | Healthcare | 22.25% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Communication Services | 10.44% |
| 5 | Consumer Staples | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Kura Oncology
KURA
$707M
| $184K | 0.03% |
8,951
-6,666
| -43% | -$137K |
|
252
CoStar Group
CSGP
$37.4B
| $182K | 0.03% |
2,456
+614
| +33% | +$45.5K |
|
253
CDW
CDW
$21.4B
| $181K | 0.03% |
808
+203
| +34% | +$45.4K |
|
254
Xcel Energy
XEL
$43.2B
| $180K | 0.03% |
3,341
+837
| +33% | +$45K |
|
255
Ligand Pharmaceuticals
LGND
$3.27B
| $178K | 0.03% |
2,112
-1,325
| -39% | -$112K |
|
256
ON Semiconductor
ON
$19.2B
| $177K | 0.03% |
2,587
+660
| +34% | +$45.2K |
|
257
Zscaler
ZS
$41.2B
| $173K | 0.02% |
901
+232
| +35% | +$44.6K |
|
258
Supernus Pharmaceuticals
SUPN
$2.52B
| $173K | 0.02% |
6,459
-4,031
| -38% | -$108K |
|
259
Dynavax Technologies
DVAX
$1.21B
| $173K | 0.02% |
15,377
-9,722
| -39% | -$109K |
|
260
Zoetis
ZTS
$67.3B
| $171K | 0.02% |
986
| – | – |
|
|
ANSS
261
DELISTED
Ansys
ANSS
| $169K | 0.02% |
525
+133
| +34% | +$42.8K |
|
262
GlobalFoundries
GFS
$18B
| $168K | 0.02% |
3,316
+845
| +34% | +$42.7K |
|
263
MannKind Corp
MNKD
$1.65B
| $167K | 0.02% |
31,994
-19,953
| -38% | -$104K |
|
264
Carnival Corp
CCL
$42.8B
| $161K | 0.02% |
8,617
-104,983
| -92% | -$1.97M |
|
265
ZIM Integrated Shipping Services
ZIM
$1.62B
| $161K | 0.02% |
+7,273
| New | +$161K |
|
266
Take-Two Interactive
TTWO
$43.9B
| $160K | 0.02% |
1,030
+261
| +34% | +$40.6K |
|
|
AVDL
267
Avadel Pharmaceuticals
AVDL
$1.44B
| $159K | 0.02% |
+11,292
| New | +$159K |
|
268
ANI Pharmaceuticals
ANIP
$2.07B
| $157K | 0.02% |
2,463
-1,570
| -39% | -$100K |
|
269
Pacira BioSciences
PCRX
$1.24B
| $156K | 0.02% |
5,468
-3,462
| -39% | -$99K |
|
270
BioCryst Pharmaceuticals
BCRX
$1.74B
| $150K | 0.02% |
24,247
-15,392
| -39% | -$95.1K |
|
271
Immunocore
IMCR
$1.76B
| $148K | 0.02% |
4,380
-2,241
| -34% | -$75.9K |
|
272
Nurix Therapeutics
NRIX
$705M
| $145K | 0.02% |
6,969
-2,435
| -26% | -$50.8K |
|
273
ChargePoint
CHPT
$243M
| $143K | 0.02% |
4,750
| – | – |
|
274
Vir Biotechnology
VIR
$760M
| $142K | 0.02% |
15,986
-9,988
| -38% | -$88.9K |
|
275
Sana Biotechnology
SANA
$736M
| $142K | 0.02% |
26,023
-16,377
| -39% | -$89.4K |
|